
David S. Romeo
Examiner (ID: 11602)
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1646, 1801, 1643 |
| Total Applications | 1149 |
| Issued Applications | 531 |
| Pending Applications | 95 |
| Abandoned Applications | 523 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10988903
[patent_doc_number] => 20160185848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING SUGARS'
[patent_app_type] => utility
[patent_app_number] => 14/795838
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 36022
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795838
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795838 | METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING SUGARS | Jul 8, 2015 | Abandoned |
Array
(
[id] => 10476159
[patent_doc_number] => 20150361175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION'
[patent_app_type] => utility
[patent_app_number] => 14/795007
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 74363
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795007
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795007 | Compositions and methods for growth factor modulation | Jul 8, 2015 | Issued |
Array
(
[id] => 11613708
[patent_doc_number] => 09651560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Methods for detecting antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/745765
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 18411
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745765
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745765 | Methods for detecting antibodies | Jun 21, 2015 | Issued |
Array
(
[id] => 10389826
[patent_doc_number] => 20150274832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'DAC HYP COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/735062
[patent_app_country] => US
[patent_app_date] => 2015-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32865
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735062
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/735062 | DAC HYP compositions and methods | Jun 8, 2015 | Issued |
Array
(
[id] => 10380666
[patent_doc_number] => 20150265673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'SURGICAL APPLICATIONS FOR BMP BINDING PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/731852
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10866
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14731852
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/731852 | Surgical applications for BMP binding protein | Jun 4, 2015 | Issued |
Array
(
[id] => 10380666
[patent_doc_number] => 20150265673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'SURGICAL APPLICATIONS FOR BMP BINDING PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/731852
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10866
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14731852
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/731852 | Surgical applications for BMP binding protein | Jun 4, 2015 | Issued |
Array
(
[id] => 11330953
[patent_doc_number] => 09522186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'M-CSF specific monoclonal antibody and uses therof'
[patent_app_type] => utility
[patent_app_number] => 14/729548
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 45
[patent_no_of_words] => 49361
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729548
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729548 | M-CSF specific monoclonal antibody and uses therof | Jun 2, 2015 | Issued |
Array
(
[id] => 11881875
[patent_doc_number] => 09753041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Salivary inflammatory biomarkers associated with glycemic control and oral health'
[patent_app_type] => utility
[patent_app_number] => 14/692548
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11088
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692548
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/692548 | Salivary inflammatory biomarkers associated with glycemic control and oral health | Apr 20, 2015 | Issued |
Array
(
[id] => 10399448
[patent_doc_number] => 20150284456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'ANTIBODIES TO TGF-BETA'
[patent_app_type] => utility
[patent_app_number] => 14/682975
[patent_app_country] => US
[patent_app_date] => 2015-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21469
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14682975
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/682975 | Antibodies to TGF-β | Apr 8, 2015 | Issued |
Array
(
[id] => 10361153
[patent_doc_number] => 20150246158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'BONE MORPHOGENIC PROTEIN BINDING PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 14/640451
[patent_app_country] => US
[patent_app_date] => 2015-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7467
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14640451
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/640451 | Bone morphogenic protein binding peptide | Mar 5, 2015 | Issued |
Array
(
[id] => 10292265
[patent_doc_number] => 20150177264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'METHODS AND KITS FOR DIAGNOSING OBSTRUCTIVE SLEEP APNEA'
[patent_app_type] => utility
[patent_app_number] => 14/641006
[patent_app_country] => US
[patent_app_date] => 2015-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14514
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14641006
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/641006 | Methods and kits for diagnosing obstructive sleep apnea | Mar 5, 2015 | Issued |
Array
(
[id] => 11827659
[patent_doc_number] => 09724388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'FGF-18 compound dosing regimen'
[patent_app_type] => utility
[patent_app_number] => 15/120134
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 9775
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120134 | FGF-18 compound dosing regimen | Feb 19, 2015 | Issued |
Array
(
[id] => 11698833
[patent_doc_number] => 09688735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Designer osteogenic proteins'
[patent_app_type] => utility
[patent_app_number] => 14/589468
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 33671
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589468
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589468 | Designer osteogenic proteins | Jan 4, 2015 | Issued |
Array
(
[id] => 10297636
[patent_doc_number] => 20150182635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'PROCESS FOR PREPARING PURIFIED DRUG CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/589541
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14249
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589541
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589541 | Process for preparing purified drug conjugates | Jan 4, 2015 | Issued |
Array
(
[id] => 10354946
[patent_doc_number] => 20150239950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'DESIGNER LIGANDS OF TGF-BETA SUPERFAMILY'
[patent_app_type] => utility
[patent_app_number] => 14/586573
[patent_app_country] => US
[patent_app_date] => 2014-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 43926
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14586573
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/586573 | DESIGNER LIGANDS OF TGF-BETA SUPERFAMILY | Dec 29, 2014 | Abandoned |
Array
(
[id] => 11928736
[patent_doc_number] => 09795714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'FGF-18 formulation in alginate/collagen hydrogels'
[patent_app_type] => utility
[patent_app_number] => 15/105710
[patent_app_country] => US
[patent_app_date] => 2014-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 17355
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105710 | FGF-18 formulation in alginate/collagen hydrogels | Dec 22, 2014 | Issued |
Array
(
[id] => 11798605
[patent_doc_number] => 09539325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Combination therapy for treating breast cancer'
[patent_app_type] => utility
[patent_app_number] => 14/562306
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16194
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562306
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562306 | Combination therapy for treating breast cancer | Dec 4, 2014 | Issued |
Array
(
[id] => 9932365
[patent_doc_number] => 20150080557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'HUMAN ANTIBODIES THAT BIND HUMAN TNF-ALPHA AND METHODS OF PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/559346
[patent_app_country] => US
[patent_app_date] => 2014-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14437
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14559346
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/559346 | HUMAN ANTIBODIES THAT BIND HUMAN TNF-ALPHA AND METHODS OF PREPARING THE SAME | Dec 2, 2014 | Abandoned |
Array
(
[id] => 9865524
[patent_doc_number] => 20150045542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'HUMAN ANTIBODIES THAT BIND HUMAN TNF-ALPHA AND METHODS OF PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/522535
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14440
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14522535
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/522535 | Human antibodies that bind human TNF-alpha and methods of preparing the same | Oct 22, 2014 | Issued |
Array
(
[id] => 10201582
[patent_doc_number] => 20150086571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST'
[patent_app_type] => utility
[patent_app_number] => 14/504544
[patent_app_country] => US
[patent_app_date] => 2014-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9785
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14504544
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/504544 | METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST | Oct 1, 2014 | Abandoned |